Bio adhesives are naturally present polymeric material and possess adhesive properties. Synthetic bio adhesives are also available in the market and have different applications such as the protection of tissues, promoting wound healing, a replacement for surgical sutures, and a replacement for conventional drug delivery systems. Bio adhesives are biocompatible products and hence are often used in biological applications and mainly in surgeries as sealants. Tissue adhesives are liquid monomers that undergo an exothermic reaction upon exposure to a moist surface (skin), changing to a polymer that forms a strong tissue bond. The wound edges are approximated and two to three layers of tissue adhesive are applied. Sealants are often used to fill gaps and resist relative movement of the surfaces to which they are applied. Even though adhesives are generally stronger, sealants provide the assembly with much more flexibility.

Topical tissue glues/adhesives are used to treat selected superficial skin wounds. They consist of liquid cyanoacrylate monomers which polymerize into long chains that hold wound edges together when they come into contact with blood or a wound surface. Tissue adhesives and sealants have revolutionized hemostasis and wound management in traumatic and surgical injuries. Various biological-driven glues and synthetic adhesives are clinically utilized either as an adjunct to conventional hemostats and wound closure techniques, such as suturing or as a replacement to them. The ability to effectively and promptly control bleeding, thus, reducing the risk of complications due to severe blood loss, in addition to convenience of use render medical adhesive a highly suitable tool for wound management. Tissue adhesives are increasingly gaining popularity in diverse areas of clinical applications, including wound closure and healing, drug delivery, implantation of medical devices, tissue engineering, and dental and bone applications.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive market growth over the forecast period. For instance, In December 2021, the BD Company sealed the deal to acquire the self-adhesive surgical sealant business of the Tissuemed, with the aim to boost the portfolio and expand the surgical offerings across the world.

Key features of the study:

• This report provides in-depth analysis of the global tissue glue and bio-adhesive sealants market and provides market size and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global tissue glue and bio-adhesive sealants market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Cryolife, Baxter International Inc., Luna Innovations Incorporated, B. Braun Melsungen AG, Johnson and Johnson, Dentsply Sirona Inc., Cohera Medical, Inc., Chemence Medical, Inc., Tissuemed Ltd., C.R. Bard Inc., and Integra LifeSciences Corporation.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global tissue glue and bio-adhesive sealants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation:

• Global Tissue Glue and Bio-Adhesive Sealants Market, By Product Type:
  • Protein Based Sealants
  • Collagen Based Sealants
  • Thrombin-based Sealants
  • Fibrin Sealant
  • Gelatin-based Sealant
  • Others
• Global Tissue Glue and Bio-Adhesive Sealants Market, By Application:
  • Cardiovascular Surgery
  • Laparoscopic Surgeries
  • Burns and Skin Grafting
  • Digestive
  • Cosmetic, Reconstructive and Hand Surgery
  • General Surgeries
  • Others
• Global Tissue Glue and Bio-Adhesive Sealants Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)
• Global Tissue Glue and Bio-Adhesive Sealants Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Cryolife, Inc. *
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Baxter International Inc.
  • Luna Innovations Incorporated
  • B.Braun Melsungen AG
  • Johnson and Johnson
  • Dentsply Sirona Inc.
  • Cohera Medical, Inc.
  • Chemence Medical, Inc.
  • Tissuemed Ltd.
  • C.R. Bard Inc.
  • Integra LifeSciences Corporation

 “*” marked represents similar segmentation in other categories in the respective section.